Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05225220 · ClinicalTrials.gov registry record · NA

Multimodal Investigation of Post COVID-19 in Females

A NA study, sponsored by Casa Colina Hospital and Centers for Healthcare.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT05225220 is a NA study that has completed, run by Casa Colina Hospital and Centers for Healthcare. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05225220, a NA study, has completed, sponsored by Casa Colina Hospital and Centers for Healthcare.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effects of transcutaneous vagus nerve stimulation (t-VNS) on Long Covid symptoms in females and to identify factors influencing susceptibility and recovery-particularly in the cognitive domain, as over 80% of long-haulers experience "brain fog".

Interventions

  • DEVICE Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve Stimulation (t-VNS)

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-03-01
Est. Completion 2023-01-06
Phase NA

What the Registry Record Tells You About NCT05225220

The ClinicalTrials.gov registry entry for NCT05225220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Casa Colina Hospital and Centers for Healthcare, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve Stimulation (t-VNS) is the first listed.

NCT05225220 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05225220 about?

NCT05225220 is a clinical study titled "Multimodal Investigation of Post COVID-19 in Females". The purpose of this study is to investigate the effects of transcutaneous vagus nerve stimulation (t-VNS) on Long Covid symptoms in females and to identify factors influencing susceptibility and recovery-particularly in the cognitive domain, as over 80% of long-haulers experience "brain fog".

What is the current status of trial NCT05225220?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-03-01. Estimated completion is 2023-01-06.

What interventions are being tested in trial NCT05225220?

The interventions under investigation include: Parasym Device (of Parasym Ltd, UK) using Transcutaneous Vagus Nerve Stimulation (t-VNS) (DEVICE).

Who is sponsoring clinical trial NCT05225220?

This trial is sponsored by Casa Colina Hospital and Centers for Healthcare, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.